Literature DB >> 22767222

Role of microRNAs in peripheral artery disease (review).

Xiangyu Zhou1, Ping Yuan, Yanzheng He.   

Abstract

Peripheral arterial disease (PAD) involves a general vascular problem of diffuse atherosclerosis. The key pathological process is characterized by the aberrant proliferation of vascular smooth muscle cells and the formation of neointimal lesions. The molecular mechanisms involved in the regulation of the occurrence and development of PAD remain unclear. microRNAs (miRNAs) are highly conserved 20-25 nt-long non-coding RNAs that negatively regulate gene expression. Recent evidence has demonstrated that specific miRNAs are involved in the pathological processes of PAD, and these miRNAs are found to be critical modulators of vascular cell functions, including cell differentiation, contraction, migration, proliferation and apoptosis. This review summarizes findings of studies regarding the roles of specific miRNAs in PAD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22767222     DOI: 10.3892/mmr.2012.978

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  13 in total

1.  Skeletal muscle MiR-210 expression is associated with mitochondrial function in peripheral artery disease patients.

Authors:  Ahmed Ismaeel; Emma Fletcher; Dimitrios Miserlis; Marissa Wechsler; Evlampia Papoutsi; Gleb Haynatzki; Robert S Smith; William T Bohannon; Panagiotis Koutakis
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

2.  Application of OpenArray RT-qPCR for identification of microRNA expression signatures of lower extremity artery disease.

Authors:  Daniel P Zalewski; Karol P Ruszel; Andrzej Stępniewski; Dariusz Gałkowski; Marcin Feldo; Janusz Kocki; Anna Bogucka-Kocka
Journal:  J Appl Genet       Date:  2022-04-02       Impact factor: 2.653

3.  RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224.

Authors:  Hongyi Liu; Peng Li; Bing Li; Peng Sun; Jiajin Zhang; Baishi Wang; Baoqing Jia
Journal:  Tumour Biol       Date:  2014-07-14

4.  miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.

Authors:  Weiguo Cao; Weiping Yang; Rong Fan; Hao Li; Jinsong Jiang; Mei Geng; Yening Jin; Yunlin Wu
Journal:  Tumour Biol       Date:  2013-09-26

5.  Analysis of Serum MicroRNAs as Potential Biomarker in Coronary Bifurcation Lesion.

Authors:  Yan Liu; Shaoliang Chen; Junjie Zhang; Shoujie Shan; Liang Chen; Rong Wang; Jing Kan; Tian Xu
Journal:  Dis Markers       Date:  2015-04-27       Impact factor: 3.434

Review 6.  Non-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genome.

Authors:  Kazuo Murakami
Journal:  Curr Hypertens Rev       Date:  2015

7.  Research Status of Differentially Expressed Noncoding RNAs in Type 2 Diabetes Patients.

Authors:  Rou Shi; Yingjian Chen; Yuanjun Liao; Rang Li; Chunwen Lin; Liangchang Xiu; Haibing Yu; Yuanlin Ding
Journal:  Biomed Res Int       Date:  2020-11-13       Impact factor: 3.411

Review 8.  Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling.

Authors:  Dmitry A Chistiakov; Igor A Sobenin; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

9.  Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer.

Authors:  Chen Zhao; Aleksander S Popel
Journal:  PLoS Comput Biol       Date:  2015-11-20       Impact factor: 4.475

Review 10.  The Role of MicroRNAs in Kidney Disease.

Authors:  Sydwell Mukhadi; Rodney Hull; Zukile Mbita; Zodwa Dlamini
Journal:  Noncoding RNA       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.